Europe Benign Prostatic Hyperplasic Devices Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Resectoscopes, Urology Laser, Radiofrequency Ablation Devices, Prostatic Stents, and Implants), Procedure Type (Transurethral Microwave Therapy, Transurethral Resection of the Prostate, Transurethral Needle Ablation of the Prostate, Laser Surgery, Urolift Surgery, and Others), and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

No. of Pages: 159    |    Report Code: BMIRE00027126    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Benign Prostatic Hyperplasic Devices Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Benign Prostatic Hyperplasic Devices Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Benign Prostatic Hyperplasic Devices Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Growing geriatric population globally.
  • 5.1.3 Increasing awareness about BPH treatments.
  • 5.1.4 Advancements in minimally invasive devices.
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Expansion in telehealth and remote care.
  • 5.2.3 Development of laser-based treatment devices.
  • 5.2.4 Demand for cost-effective solutions.
5.3 Future Trends
  • 5.3.1
  • 5.3.2 AI integration in diagnostic tools.
  • 5.3.3 Personalized BPH treatment approaches.
  • 5.3.4 Growing adoption of robotic-assisted devices.
5.4 Impact of Drivers and Restraints

6. Europe Benign Prostatic Hyperplasic Devices Market Regional Analysis

6.1 Europe Benign Prostatic Hyperplasic Devices Market Overview
6.2 Europe Benign Prostatic Hyperplasic Devices Market Revenue 2020-2028 (US$ Million)
6.3 Europe Benign Prostatic Hyperplasic Devices Market Forecast Analysis

7. Europe Benign Prostatic Hyperplasic Devices Market Analysis – by Product

7.1 Resectoscopes
  • 7.1.1 Overview
  • 7.1.2 Resectoscopes: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Urology Laser
  • 7.2.1 Overview
  • 7.2.2 Urology Laser: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Radiofrequency Ablation Devices
  • 7.3.1 Overview
  • 7.3.2 Radiofrequency Ablation Devices: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Prostatic Stents
  • 7.4.1 Overview
  • 7.4.2 Prostatic Stents: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Implants
  • 7.5.1 Overview
  • 7.5.2 Implants: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Benign Prostatic Hyperplasic Devices Market Analysis – by Procedure Type

8.1 Transurethral Microwave Therapy
  • 8.1.1 Overview
  • 8.1.2 Transurethral Microwave Therapy: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Transurethral Resection of the Prostate
  • 8.2.1 Overview
  • 8.2.2 Transurethral Resection of the Prostate: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Transurethral Needle Ablation of the Prostate
  • 8.3.1 Overview
  • 8.3.2 Transurethral Needle Ablation of the Prostate: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Laser Surgery
  • 8.4.1 Overview
  • 8.4.2 Laser Surgery: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Urolift Surgery
  • 8.5.1 Overview
  • 8.5.2 Urolift Surgery: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Benign Prostatic Hyperplasic Devices Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Urolift Surgery: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Urolift Surgery: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Ambulatory Surgical Centers
  • 9.3.1 Overview
  • 9.3.2 Urolift Surgery: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Benign Prostatic Hyperplasic Devices Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.1.2 UK: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.1.3 UK: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.2.2 Germany: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.2.3 Germany: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.3 France: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.3.2 France: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.3.3 France: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.4.2 Russia: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.4.3 Russia: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.5.2 Italy: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.5.3 Italy: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Benign Prostatic Hyperplasic Devices Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Product
    • 10.1.1.6.2 Rest of Europe: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by Procedure Type
    • 10.1.1.6.3 Rest of Europe: Europe Benign Prostatic Hyperplasic Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Benign Prostatic Hyperplasic Devices Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 KARL STORZ SE & Co. KG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Olympus Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Boston Scientific Corporation
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Teleflex Incorporated
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Richard Wolf GmbH
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 GmbH
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Europe Benign Prostatic Hyperplasic Devices Market

  1. KARL STORZ SE & Co. KG
  2. Olympus Corporation
  3. Boston Scientific Corporation
  4. Teleflex Incorporated
  5. Richard Wolf GmbH
  6. GmbH